NCT00704626
Serum Auto-Antibodies in Neurological Diseases
Enrolling by Invitation
Not specifiedAges 18+ObservationalUniversity of California, DavisInvestigator-initiated
~120 participants
Updated 2026-05-18 on ClinicalTrials.gov
What's tested:Blood DrawCheek swab
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
If the serum is positive for specific antibody binding, additional serum samples may be obtained and retested up to 8 more times approximately 3 months apart.
Measured over 3 months
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Study leadership
- David Richman, MD · PRINCIPAL_INVESTIGATOR · University of California, Davis
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
18 years or older
Diagnosis of multiple sclerosis, myasthenia gravis, or other autoimmune or inflammatory neurological disease
Exclusion
inability to give informed consent
What this trial measures
- If the serum is positive for specific antibody binding, additional serum samples may be obtained and retested up to 8 more times approximately 3 months apart.3 months